Structure Therapeutics (GPCR) Current Assets (2022 - 2026)

Structure Therapeutics' Current Assets history runs 5 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• In Q1 2026, Current Assets rose 75.44% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (up 75.44% YoY), while the FY2025 annual figure was $1.6 billion, up 76.2% from the prior year.
• Current Assets was $1.5 billion for Q1 2026 at Structure Therapeutics, down from $1.6 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.6 billion in Q4 2025 to a low of $93.1 million in Q4 2022.
• Historically, Current Assets has averaged $712.6 million across 5 years, with a median of $806.7 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Current Assets jumped 408.77% in 2023, then declined 14.75% in 2025.
• A 5-year view of Current Assets shows it stood at $93.1 million in 2022, then surged by 408.77% to $473.6 million in 2023, then surged by 88.17% to $891.2 million in 2024, then surged by 76.2% to $1.6 billion in 2025, then dropped by 5.08% to $1.5 billion in 2026.
• The last three Current Assets figures came in at $1.5 billion (Q1 2026), $1.6 billion (Q4 2025), and $814.0 million (Q3 2025), per Business Quant data.